Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: In Silico Identification of Piperazine Linked Thiohydantoin Derivatives as Novel Androgen Antagonist in Prostate Cancer Treatment, International Journal of Peptide Research and Therapeutics, July 2018, Springer Science + Business Media,
DOI: 10.1007/s10989-018-9734-5.
You can read the full text:

Read

Contributors

The following have contributed to this page